Ventana's companion Dx to lung cancer drug wins Chinese approval

09/12/2013 | GenomeWeb Daily News (free registration)

Ventana Medical Systems received approval in China for its Ventana ALK Rabbit Monoclonal Primary Antibody test, which is used to pinpoint patients with nonsmall cell lung cancer who are positive for the anaplastic lymphoma kinase fusion gene. The assay has been approved for use as a companion diagnostic test to Pfizer's lung cancer drug Xalkori.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC